NCT05356039 Survival, Quality of Life and Resectability in Locally Advanced Pancreatic Cancer
| NCT ID | NCT05356039 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Umeå University |
| Condition | Pancreas Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 300 participants |
| Start Date | 2022-04-19 |
| Primary Completion | 2025-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 300 participants in total. It began in 2022-04-19 with a primary completion date of 2025-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to assess overall survival, quality of life and resection rates in locally advanced pancreatic cancer
Eligibility Criteria
Inclusion Criteria: * Confirmed or suspected invasive pancreatic primary tumor * Tumor classified as borderline resectable or locally advanced disease according to NCCN guidelines Exclusion Criteria: * Suspected endocrine tumor * Suspected non-pancreatic periampullary tumor * Distant metastasis * Age \< 18 years * Patient unable to understand verbal or written information interfering with informed consent or treatment * Mental or organic disorder interfering with informed consent or treatments
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05356039 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Pancreas Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05356039 currently recruiting?
Yes, NCT05356039 is actively recruiting participants. Contact the research team at oskar.franklin@umu.se for enrollment information.
Where is the NCT05356039 trial being conducted?
This trial is being conducted at Umeå, Sweden.
Who is sponsoring the NCT05356039 clinical trial?
NCT05356039 is sponsored by Umeå University. The trial plans to enroll 300 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.